DE69122264D1 - Substituierte 1,3-oxathiolane mit antiviralen eigenschaften - Google Patents

Substituierte 1,3-oxathiolane mit antiviralen eigenschaften

Info

Publication number
DE69122264D1
DE69122264D1 DE69122264T DE69122264T DE69122264D1 DE 69122264 D1 DE69122264 D1 DE 69122264D1 DE 69122264 T DE69122264 T DE 69122264T DE 69122264 T DE69122264 T DE 69122264T DE 69122264 D1 DE69122264 D1 DE 69122264D1
Authority
DE
Germany
Prior art keywords
substituted
unsubstituted
oxathiolans
antiviral properties
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69122264T
Other languages
English (en)
Other versions
DE69122264T2 (de
Inventor
Bernard Belleau
Livio Brasili
Nghe Nguyen-Ba
Chan Laval
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shire Canada Inc
Original Assignee
IAF BioChem International Inc
Biochem Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IAF BioChem International Inc, Biochem Pharma Inc filed Critical IAF BioChem International Inc
Application granted granted Critical
Publication of DE69122264D1 publication Critical patent/DE69122264D1/de
Publication of DE69122264T2 publication Critical patent/DE69122264T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Virology (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69122264T 1990-11-13 1991-11-12 Substituierte 1,3-oxathiolane mit antiviralen eigenschaften Expired - Lifetime DE69122264T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61284090A 1990-11-13 1990-11-13
PCT/CA1991/000407 WO1992008717A1 (en) 1990-11-13 1991-11-12 Substituted 1,3-oxathiolanes and substituted 1,3-dithiolanes with antiviral properties

Publications (2)

Publication Number Publication Date
DE69122264D1 true DE69122264D1 (de) 1996-10-24
DE69122264T2 DE69122264T2 (de) 1997-02-06

Family

ID=24454850

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69122264T Expired - Lifetime DE69122264T2 (de) 1990-11-13 1991-11-12 Substituierte 1,3-oxathiolane mit antiviralen eigenschaften

Country Status (11)

Country Link
EP (1) EP0560794B1 (de)
JP (1) JP2960164B2 (de)
AT (1) ATE143016T1 (de)
AU (1) AU8864191A (de)
CA (1) CA2095613C (de)
DE (1) DE69122264T2 (de)
DK (1) DK0560794T3 (de)
ES (1) ES2091948T3 (de)
GR (1) GR3021074T3 (de)
HK (1) HK12597A (de)
WO (1) WO1992008717A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6175008B1 (en) * 1988-04-11 2001-01-16 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
DK0674634T3 (da) * 1989-02-08 2003-08-04 Iaf Biochem Int Fremgangsmåde til fremstilling af substituerede 1,3-oxathiolaner med antivirale egenskaber
US6703396B1 (en) 1990-02-01 2004-03-09 Emory University Method of resolution and antiviral activity of 1,3-oxathiolane nuclesoside enantiomers
US5276151A (en) * 1990-02-01 1994-01-04 Emory University Method of synthesis of 1,3-dioxolane nucleosides
US5587480A (en) * 1990-11-13 1996-12-24 Biochem Pharma, Inc. Substituted 1,3-oxathiolanes and substituted 1,3-dithiolanes with antiviral properties
US6369066B1 (en) 1990-11-13 2002-04-09 Biochem Pharma, Inc. Substituted 1,3-oxathiolanes with antiviral properties
US6228860B1 (en) * 1990-11-13 2001-05-08 Biochem Pharma Inc. Substituted 1,3-oxathiolanes with antiviral properties
US5444063A (en) * 1990-12-05 1995-08-22 Emory University Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity
IL100502A (en) * 1991-01-03 1995-12-08 Iaf Biochem Int PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (-
IL100965A (en) * 1991-02-22 1999-12-31 Univ Emory 2 - Hydroxymethyl - 5 -) 5 - Fluorocytocin - 1 - Eyal (- 1, 3 - Oxathiolane, its resolution and pharmaceuticals containing it
US6812233B1 (en) 1991-03-06 2004-11-02 Emory University Therapeutic nucleosides
GB9104740D0 (en) * 1991-03-06 1991-04-17 Wellcome Found Antiviral nucleoside combination
GB9110874D0 (en) * 1991-05-20 1991-07-10 Iaf Biochem Int Medicaments
US6005107A (en) * 1992-12-23 1999-12-21 Biochem Pharma, Inc. Antiviral compounds
US6444656B1 (en) 1992-12-23 2002-09-03 Biochem Pharma, Inc. Antiviral phosphonate nucleotides
GB9226879D0 (en) * 1992-12-23 1993-02-17 Iaf Biochem Int Anti-viral compounds
US20020120130A1 (en) 1993-09-10 2002-08-29 Gilles Gosselin 2' or 3' -deoxy and 2', 3' -dideoxy-beta-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti- viral agents
FR2720397B1 (fr) * 1994-05-24 1996-08-23 Laphal Laboratoires Sa Nouveaux oxathiolanes, leur procédé de préparation et les compositions pharmaceutiques qui en renferment.
ATE346651T1 (de) 1995-06-07 2006-12-15 Univ Emory Nucleoside mit anti-hepatitis b virus wirksamkeit
EP1023284B1 (de) * 1996-07-05 2005-11-23 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Gesättigte 1,2-dithiaheterocyclische verbindungen enthaltende antivirale pharmazeutische zubereitungen
IT1290447B1 (it) 1997-03-28 1998-12-03 Zambon Spa Derivati 1,3-ossatiolanici ad attivita' antivirale
EA004767B1 (ru) 1998-12-23 2004-08-26 Шайре Байокем Инк. Аналоги нуклеозида (варианты) и их применение, комбинация и способ лечения вирусных инфекций, фармацевтическая композиция
BR0104461A (pt) * 2000-02-10 2002-08-06 Mitsui Chemicals Inc Processo seletivo para produzir um anÈmero a partir de um derivado de sacarìdeo 1-fosforilado e processo para produzir um nucleosìdeo
WO2002051852A1 (fr) * 2000-12-27 2002-07-04 Mitsui Chemicals, Inc. Procede de production d'un derive de saccharide non naturel
DK1632490T3 (da) * 2001-06-15 2008-01-28 Shire Biochem Inc Stereoselektiv fremgangsmåde til fremstillingen af nukleosidanaloger
US7501514B1 (en) 2003-10-15 2009-03-10 Shire Biochem, Inc. Enantiomeric resolution of 2-substituted 4-substituted 1,3-oxathiolanes nucleosides
MX2007011274A (es) * 2005-03-14 2008-03-13 Shire Canada Inc Procesos y metodos para la preparacion de cis-2-hidroximetil-4-(ci tosin-1-il)-1,3-oxatiolano opticamente activas o sales aceptables farmaceuticamente del mismo.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8701605D0 (sv) * 1987-04-16 1987-04-16 Astra Ab Novel medicinal compounds
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
NZ228645A (en) * 1988-04-11 1991-09-25 Iaf Biochem Int 1,3-dioxolane derivatives substituted in the 5th position by a purine or pyrimidine radical; treatment of viral infections

Also Published As

Publication number Publication date
CA2095613A1 (en) 1992-05-14
JPH06504266A (ja) 1994-05-19
AU8864191A (en) 1992-06-11
ES2091948T3 (es) 1996-11-16
GR3021074T3 (en) 1996-12-31
WO1992008717A1 (en) 1992-05-29
CA2095613C (en) 2001-01-02
ATE143016T1 (de) 1996-10-15
DE69122264T2 (de) 1997-02-06
EP0560794A1 (de) 1993-09-22
JP2960164B2 (ja) 1999-10-06
DK0560794T3 (da) 1996-12-23
EP0560794B1 (de) 1996-09-18
HK12597A (en) 1997-02-14

Similar Documents

Publication Publication Date Title
ATE143016T1 (de) Substituierte 1,3-oxathiolane mit antiviralen eigenschaften
DK0674634T3 (da) Fremgangsmåde til fremstilling af substituerede 1,3-oxathiolaner med antivirale egenskaber
ATE102193T1 (de) Thiazolidinedionederivate.
ES2069137T3 (es) Derivados de imidazopiridina y su uso.
ES2091212T3 (es) Compuestos de xantina.
DE69016899D1 (de) Thiazolidinedionederivate.
NO178930C (no) Analogifremgangsmåte ved fremstilling av antivirale pyrimidinnukleosider
PT1153924E (pt) 1,3-oxatiolanos substituidos com propriedades anti-virais
MD1007C2 (ro) 1,3-Oxatiolan,izomeri geometrici şi optici ai lui,amestecurile acestor izomeri, procedeu de obţinere a lor şi compoziţie farmaceutică care manifestă activitate antivirotică
ES2055235T3 (es) Composicion anti-inflamatoria y/o antialergica que comprende derivados de glutation.
ES2046641T3 (es) Composicion antitumoral.
NO904187D0 (no) Benzanilider.
DE69001004D1 (de) Zusammensetzung gegen leberkrankheiten.
FI932691A (fi) Nya benzyl- och benzhydrylalkoholer
KR910004621A (ko) 신규 화합물
IL87107A0 (en) Naphthothiazepine derivatives,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SHIRE BIOCHEM INC., ST.LAURENT, QUEBEC, CA

8327 Change in the person/name/address of the patent owner

Owner name: SHIRE CANADA INC., ST. LAURENT, QUEBEC, CA